Gilead and Boehringer Ingelheim sign license agreement for novel HIV non-catalytic integrase inhibitors
5 October 2011 | By Gilead Sciences
Gilead Sciences, Inc. and Boehringer Ingelheim have entered into a licensing agreement...
List view / Grid view
News
Lundbeck appoints three Vice Presidents in Supply Operations & Engineering
5 October 2011 | By H. Lundbeck A/S
Lundbeck has appointed Kristian Sibilitz, Christian Houborg and Lene Andersen as Vice Presidents in Supply Operations & Engineering...
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding US SEROQUEL XR® patent litigation
5 October 2011 | By Astrazeneca
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. & Intas Pharmaceuticals Ltd...
BRILIQUE receives a positive preliminary medical benefit assessment for the majority of ACS patients in Germany as part of new AMNOG review process
4 October 2011 | By AstraZeneca
Report published on BRILIQUE (ticagrelor)...
Abbott enrolls first U.S. patient in global EXCEL trial
4 October 2011 | By Abbott
Abbott's EXCEL is the largest trial to date designed to evaluate optimal treatment strategy in patients with unprotected left main disease...
Pfizer launches new BeneFIX® room temperature storage packs for haemophilia B in Europe
3 October 2011 | By Ogilvy Healthworld UK Limited
Pfizer announce the launch of BeneFIX® with Room Temperature Storage (RTS)....
B&W Tek introduces next generation handheld Raman instrument for material verification in cGMP compliant facilities
3 October 2011 | By B&W Tek
B&W Tek, Inc., is proud to introduce the NanoRam™...
Takeda receives positive CHMP opinion in Europe for EdarbiTM (azilsartan medoxomil)
29 September 2011 | By Takeda Pharmaceutical Company Limited
The CHMP has issued a positive opinion for EdarbiTM (azilsartan medoxomil)...
Tecan’s new MCA 384 Disposable Tips offer enhanced pipetting flexibility
27 September 2011 | By kdm communications limited
Tecan has launched a new generation of high quality MCA 384 Disposable Tips...
BIBF 1120* in patients with metastatic colorectal cancer as effective as bevacizumab with less serious adverse events
27 September 2011 | By Boehringer Ingelheim
Results from a Phase I/II study...
Novartis receives approval in Japan for two innovative therapies, Gilenya® in MS and Ilaris® in CAPS
27 September 2011 | By Novartis
Novartis has received regulatory approval in Japan for once-daily Gilenya (fingolimod)...
New data shows potential of respiratory portfolio to help COPD patients maintain active and productive lives
27 September 2011 | By Novartis
Novartis has presented new Phase III data at the ERS congress...
Your successful start in microencapsulation
26 September 2011 | By Buchi
The Encapsulator B-390 & B-395 Pro, are designed for the immobilization of enzymes, drugs...
Boehringer Ingelheim expands its business with Biosimilars
26 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim will establish a new separate business for the development and commercialization of own biosimilars...
Wyatt Technology’s FFF-MALS Provides Efficient Liposome Characterization
26 September 2011 | By The Scott Partnership
Field Flow Fractionation (FFF) technology announced...
